Lebetase
Latest Information Update: 07 May 2002
At a glance
- Originator Nonindustrial source
- Class Anticoagulants; Metalloendopeptidases
- Mechanism of Action Fibrinogen inhibitors; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 18 Jan 2000 New profile
- 18 Jan 2000 Preclinical development for Thrombosis in Estonia (Unknown route)
- 18 Jan 2000 Preclinical development for Thrombosis in USA (Unknown route)